Sarecyclinesarecycline for acne, sarecycline availability
Sarecycline initially known as WC-3035 is a tetracycline-derived antibiotic
Paratek Pharmaceuticals, Inc licensed the US rights to sarecycline for the treatment of acne in the United States to Actavis, a subsidiary of Allergan, while retaining rights in the rest of the world
Allergan initiated a Phase 3 study in December 2014 evaluating the efficacy and safety of sarecycline tablets 15 mg/kg per day taken orally for 12 weeks versus placebo in the treatment of acne vulgaris Two phase 3 randomized, multi-center, double-blind, placebo-controlled studies evaluating the efficacy and safety of sarecycline in moderate to severe acne reported positive results on 27 March 2017
- ^ https://wwwbloombergcom/research/stocks/snapshot/snapshot_articleaspticker=N4CN:GR&txtsize=s
- ^ https://clinicaltrialsgov/ct2/show/NCT02320149
- ^ "Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne" wwwglobenewswirecom Retrieved 16 May 2017
|This systemic antibiotic-related article is a stub You can help Wikipedia by expanding it
sarecycline, sarecycline acne, sarecycline actavis, sarecycline allergan, sarecycline approval, sarecycline availability, sarecycline for acne, sarecycline for rosacea, sarecycline trials, sarecycline wiki
Sarecycline Information about
Sarecycline viewing the topic.
There are excerpts from wikipedia on this article and video
We have prepared this method why you can reach most accurate and most up to date knowladge. The search engine that developed for you transmits you to the latest and exact information with its basic and quick system.
You can find nearly everything data which found from internet with this system.